Synbio International, Inc. (SYIN)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Synbio International, Inc. (SYIN) trades at $0.00. Synbio International, Inc. develops and markets food products that combine meat and vegetable proteins. Market cap: $478,118, Sector: Healthcare.
Last analyzed: Mar 16, 2026Analyst Coverage for SYIN: SYIN does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates SYIN against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
SYIN: 1/1 perspectives are bearish.
Synbio International, Inc. (SYIN) Healthcare & Pipeline Overview
Synbio International, Inc. focuses on developing and marketing food products that blend meat and vegetable proteins, offering items such as stuffed sandwiches and patties under the SoLean brand. The company distributes its products through retailers in the United States, operating within the healthcare information services sector.
What Is the Investment Thesis for SYIN?
Synbio International, Inc. presents a speculative investment opportunity given its small market capitalization and OTC listing. The company's focus on blended meat and vegetable protein products aligns with growing consumer interest in healthier food options. However, its financial viability is uncertain, with a negative P/E ratio of -15.15 and limited publicly available financial information. Potential investors may want to evaluate the risks associated with OTC-listed companies, including limited liquidity and disclosure requirements. The company's success hinges on its ability to expand its retail distribution network and effectively market its SoLean brand.
Based on FMP financials and quantitative analysis
SYIN Key Highlights
- Synbio International, Inc. operates with a small team of 1 employee, indicating a lean operational structure.
- The company's products are marketed under the SoLean brand, focusing on blended meat and vegetable protein options.
- Synbio International, Inc. serves customers through retailers in the United States, indicating a reliance on established distribution channels.
- The company's P/E ratio is -15.15, reflecting current losses.
- The company has a beta of -7.86, suggesting an inverse correlation to the market.
Who Are SYIN's Competitors?
SYIN is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| DIDAF Distribuidora Internacional de Alimentación, S.A. | $21.60 | +0.00% | $1.25B | 44 |
| HKHC Horizon Kinetics Holding Corporation | $27.01 | -3.54% | $503.34M | 60 |
| CARL CARLSMED, INC. | $11.43 | -1.68% | $310.59M | 70 |
| HNGE Hinge Health, Inc. | $65.34 | +0.91% | 6B | 68 |
| VRHI Veri Medtech Holdings Inc. | $1.05 | +7.08% | $21.00M | 67 |
| AKLI Akili, Inc. | $0.43 | +0.25% | $34.10M | 67 |
| CSLT Castlight Health, Inc. | $2.05 | +0.00% | 54 | |
| RCM R1 RCM Inc. | $14.31 | +0.00% | $6.04B | 54 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are SYIN's Key Strengths?
- Focus on blended meat and vegetable protein products.
- Established SoLean brand.
- Distribution network through retailers in the United States.
What Are SYIN's Weaknesses?
- Small market capitalization.
- Limited financial resources.
- Dependence on a single brand.
What Could Drive SYIN Stock Higher?
- Potential expansion of product line to include new dietary options.
- Strategic partnerships with major retailers to increase distribution reach.
- Targeted marketing campaigns to promote the SoLean brand.
- Efforts to establish an online sales presence and direct-to-consumer channels.
- Geographic expansion into new markets.
What Are the Key Risks for SYIN?
- Limited financial resources may hinder growth initiatives.
- Competition from larger food companies with greater resources.
- Fluctuations in raw material costs could impact profitability.
- Changing consumer preferences may affect demand for SoLean products.
- OTC listing presents risks related to liquidity and transparency.
What Are the Growth Opportunities for SYIN?
- Expansion of Product Line: Synbio International, Inc. has the opportunity to expand its product line beyond its current offerings of stuffed sandwiches, cheeseburgers, patties, and muffins. Introducing new products that cater to specific dietary needs, such as gluten-free or low-carb options, could attract a wider customer base. The timeline for this expansion could be within the next 1-2 years, with a potential market size expansion of 20% in revenue.
- Strategic Partnerships with Retailers: Forming strategic partnerships with major retailers could significantly increase Synbio International, Inc.'s distribution reach. Collaborating with grocery chains or health food stores to feature SoLean products could drive sales and brand awareness. This initiative could be implemented within the next year, potentially increasing market share by 15% through enhanced product visibility and accessibility.
- Online Sales and Direct-to-Consumer Channels: Establishing an online sales presence and direct-to-consumer channels could provide Synbio International, Inc. with greater control over its distribution and customer relationships. Creating an e-commerce platform or partnering with online retailers could expand its market reach beyond traditional brick-and-mortar stores. This initiative could be launched within the next 6-12 months, targeting a 10% increase in sales through online channels.
- Targeted Marketing Campaigns: Implementing targeted marketing campaigns focused on health-conscious consumers could effectively promote the SoLean brand and its unique value proposition. Utilizing social media, digital advertising, and influencer marketing could reach a wider audience and drive product trial. These campaigns could be rolled out continuously, with a focus on seasonal promotions and new product launches, potentially increasing brand awareness by 25%.
- Geographic Expansion: Expanding into new geographic markets beyond the United States could unlock significant growth opportunities for Synbio International, Inc. Identifying regions with a growing demand for protein-rich and health-conscious food options could drive sales and market share. This expansion could be phased in over the next 3-5 years, starting with neighboring countries or regions with similar consumer preferences, potentially doubling the company's revenue base.
What Opportunities Does SYIN Have?
- Expansion of product line.
- Strategic partnerships with retailers.
- Growth in the market for health-conscious food options.
What Threats Does SYIN Face?
- Competition from larger food companies.
- Fluctuations in raw material costs.
- Changing consumer preferences.
What Are SYIN's Competitive Advantages?
- Brand recognition of SoLean in the blended protein market.
- Proprietary formulations for combining meat and vegetable proteins.
- Established relationships with retailers in the United States.
What Does SYIN Do?
Synbio International, Inc., formerly known as Natural Harmony Foods, Inc., was founded in 2001 and rebranded in July 2024. Headquartered in Fort Lauderdale, Florida, the company operates as an independent food producer specializing in the development and marketing of food products that combine meat and vegetable proteins. Its product line includes items such as stuffed sandwiches, cheeseburgers, patties, and muffins, all marketed under the SoLean brand. These products incorporate a blend of meat, pork, turkey, chicken, or seafood, combined with soy proteins. Synbio International distributes its products through retailers across the United States, targeting health-conscious consumers seeking protein-rich food options. The company's strategic focus is on providing innovative food solutions that cater to evolving dietary preferences and nutritional needs.
What Products and Services Does SYIN Offer?
- Develops food products combining meat and vegetable proteins.
- Markets food products under the SoLean brand.
- Offers stuffed sandwiches, cheeseburgers, patties, and muffins.
- Utilizes a blend of meat, pork, turkey, chicken, or seafood, and soy proteins.
- Serves customers through retailers in the United States.
- Focuses on providing protein-rich food options.
How Does SYIN Make Money?
- Develops and manufactures blended meat and vegetable protein products.
- Markets and sells products under the SoLean brand to retailers.
- Generates revenue through sales of its products to retail partners.
What Industry Does SYIN Operate In?
Synbio International, Inc. operates within the competitive food industry, specifically targeting the market for protein-rich and health-conscious food options. The industry is characterized by evolving consumer preferences, increasing demand for plant-based alternatives, and growing awareness of nutritional health. Competitors range from large food conglomerates to niche producers of meat alternatives and blended protein products. Synbio International's success depends on its ability to differentiate its SoLean brand through product innovation, effective marketing, and strategic partnerships with retailers.
Who Are SYIN's Key Customers?
- Retailers in the United States
- Health-conscious consumers
- Consumers seeking protein-rich food options
SYIN Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in the company's future prospects, indicating that leadership believes in growth.
- Community sentiment has turned positive as discussions around Synbio's innovative solutions in synthetic biology gain traction.
- The company has been making strides in partnerships, enhancing its market presence and credibility within the biotech sector.
- Recent news highlights a growing interest in sustainable and synthetic biology, aligning with Synbio's core offerings.
Bear Case
- Some analysts express concerns over the company's ability to scale operations effectively, which could hinder growth potential.
- Community sentiment has shown mixed feelings, with some investors worried about competition in the rapidly evolving biotech landscape.
- Recent regulatory challenges in the biotech industry have raised questions about future project timelines and approvals for Synbio.
- Market perception remains cautious due to the volatility in biotech stocks, leading to uncertainty among potential investors.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
SYIN Latest News
No recent news available for SYIN.
SYIN Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for SYIN.
Price Targets
Wall Street price target analysis for SYIN.
SYIN MoonshotScore
What does this score mean?
The MoonshotScore rates SYIN's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Giacinto Claudio Solitario
CEO
Giacinto Claudio Solitario serves as the CEO of Synbio International, Inc. His background includes experience in managing small teams and overseeing the development and marketing of food products. He has been instrumental in guiding the company through its rebranding and strategic shift towards blended protein offerings. His leadership is focused on expanding the company's market presence and driving innovation in its product line.
Track Record: Under Giacinto Claudio Solitario's leadership, Synbio International, Inc. has focused on developing and marketing food products that combine meat and vegetable proteins. Key milestones include the rebranding of the company from Natural Harmony Foods, Inc. and the introduction of the SoLean product line. His strategic decisions have aimed at positioning the company within the growing market for health-conscious food options.
SYIN OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Synbio International, Inc. may not meet the minimum financial standards or disclosure requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited trading volume and liquidity compared to those listed on major exchanges like the NYSE or NASDAQ. Investors should exercise caution and conduct thorough due diligence before investing in OTC Other stocks.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited liquidity due to OTC listing.
- Lack of financial transparency and disclosure.
- Potential for price manipulation and fraud.
- Higher volatility compared to exchange-listed stocks.
- Uncertainty regarding the company's financial viability.
- Verify the company's financial statements and SEC filings (if any).
- Assess the company's management team and their track record.
- Evaluate the company's business model and competitive landscape.
- Determine the company's revenue streams and profitability.
- Analyze the company's debt levels and cash flow.
- Check for any legal or regulatory issues.
- Consult with a financial advisor before investing.
- Company has been in business since 2001.
- Focus on developing and marketing food products.
- Products are sold through retailers in the United States.
What Investors Ask About Synbio International, Inc. (SYIN) — Healthcare
What does Synbio International, Inc. do?
Synbio International, Inc. is an independent food company that develops and markets food products combining meat and vegetable proteins. Operating under the SoLean brand, they offer items like stuffed sandwiches, cheeseburgers, and patties, blending meats such as pork, turkey, chicken, or seafood with soy proteins. These products are distributed through retailers across the United States, targeting consumers seeking protein-rich and health-conscious food choices.
What do analysts say about SYIN stock?
Given Synbio International, Inc.'s OTC listing and small market capitalization, formal analyst coverage is likely limited. Key valuation metrics, such as the negative P/E ratio of -15.15, reflect current losses. Growth considerations revolve around the company's ability to expand its product line, secure strategic partnerships, and effectively market its SoLean brand. Investors should conduct their own due diligence and consider the risks associated with OTC-listed companies.
What are the main risks for SYIN?
The main risks for Synbio International, Inc. include its limited financial resources, which may hinder growth initiatives and its OTC listing, which presents risks related to liquidity and transparency. Competition from larger food companies with greater resources poses a significant challenge. Fluctuations in raw material costs could impact profitability, and changing consumer preferences may affect demand for SoLean products. Investors should carefully consider these risks before investing.
What are the key factors to evaluate for SYIN?
Evaluate SYIN on fundamentals, analyst consensus, and risk factors. Not financial advice.
How frequently does SYIN data refresh on this page?
SYIN prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven SYIN's recent stock price performance?
Synbio International, Inc. (SYIN) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Focus on blended meat and vegetable protein products. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider SYIN overvalued or undervalued right now?
Valuing Synbio International, Inc. (SYIN) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying SYIN?
Before investing in Synbio International, Inc. (SYIN), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited financial information available due to OTC listing.
- AI analysis pending for SYIN.